GW & Wade’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

GW & Wade’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-80,000	Closed	-$8K	–	243
2016 Q3	$8K	Hold	80,000	–	–	﹤0.01%	229
2016 Q2	$30K	Hold	80,000	–	–	0.01%	233
2016 Q1	$30K	Hold	80,000	–	–	0.01%	213
2015 Q4	$31K	Buy	80,000 +50,000	+167%	+$23.7K	0.01%	216
2015 Q3	$17K	Hold	30,000	–	–	﹤0.01%	219
2015 Q2	$16K	Hold	30,000	–	–	﹤0.01%	231
2015 Q1	$24K	Buy	+30,000	New	+$24.7K	﹤0.01%	238

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

GW & Wade's PVCT Position: Q4 2016 in Review

GW & Wade sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 80,000 shares — an estimated $8K sold.

GW & Wade first reported a position in PVCT in Q1 2015 and held it in 7 quarters. The position peaked at $31K in Q4 2015. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

GW & Wade reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
GW & Wade sold 80,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $8K.
GW & Wade first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q1 2015 and held it in 7 quarters.
GW & Wade's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $31K in Q4 2015.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on GW & Wade's 13F filing for Q4 2016, filed 25 Jan 2017.